Brian Abrahams

Stock Analyst at RBC Capital

(2.24)
# 2,800
Out of 5,040 analysts
439
Total ratings
42.68%
Success rate
-3.56%
Average return

Stocks Rated by Brian Abrahams

Galapagos NV
Oct 22, 2025
Maintains: Sector Perform
Price Target: $27$28
Current: $32.60
Upside: -14.11%
MoonLake Immunotherapeutics
Sep 29, 2025
Downgrades: Sector Perform
Price Target: $67$10
Current: $9.34
Upside: +7.07%
Apogee Therapeutics
Sep 25, 2025
Initiates: Outperform
Price Target: $60
Current: $53.35
Upside: +12.46%
Incyte
Sep 24, 2025
Maintains: Sector Perform
Price Target: $72$81
Current: $88.00
Upside: -7.95%
aTyr Pharma
Sep 16, 2025
Downgrades: Sector Perform
Price Target: $16$1.5
Current: $0.97
Upside: +54.80%
Kymera Therapeutics
Sep 16, 2025
Initiates: Outperform
Price Target: $70
Current: $55.98
Upside: +25.04%
Neurocrine Biosciences
Sep 5, 2025
Maintains: Outperform
Price Target: $144$149
Current: $142.64
Upside: +4.46%
Sionna Therapeutics
Sep 3, 2025
Initiates: Sector Perform
Price Target: $22
Current: $39.51
Upside: -44.32%
Xenon Pharmaceuticals
Sep 2, 2025
Reiterates: Outperform
Price Target: $55
Current: $41.80
Upside: +31.58%
Aardvark Therapeutics
Aug 14, 2025
Maintains: Outperform
Price Target: $20$19
Current: $10.95
Upside: +73.52%
Maintains: Outperform
Price Target: $60$63
Current: $66.72
Upside: -5.57%
Maintains: Sector Perform
Price Target: $96$98
Current: $120.26
Upside: -18.51%
Maintains: Sector Perform
Price Target: $12$11
Current: $14.82
Upside: -25.75%
Maintains: Outperform
Price Target: $39$40
Current: $21.15
Upside: +89.13%
Maintains: Sector Perform
Price Target: $430$405
Current: $429.58
Upside: -5.72%
Maintains: Sector Perform
Price Target: $18$10
Current: $9.81
Upside: +1.94%
Maintains: Sector Perform
Price Target: $688$695
Current: $575.34
Upside: +20.80%
Maintains: Outperform
Price Target: $208$219
Current: $147.89
Upside: +48.08%
Maintains: Sector Perform
Price Target: $25$23
Current: $21.58
Upside: +6.58%
Reiterates: Outperform
Price Target: $13
Current: $7.20
Upside: +80.68%
Maintains: Outperform
Price Target: $35$75
Current: $98.03
Upside: -23.49%
Reiterates: Outperform
Price Target: $31
Current: $11.11
Upside: +179.03%
Reiterates: Sector Perform
Price Target: $1.5
Current: $1.31
Upside: +14.94%
Maintains: Outperform
Price Target: $34$33
Current: $6.33
Upside: +421.33%
Maintains: Outperform
Price Target: $65$58
Current: $17.90
Upside: +224.02%
Reiterates: Outperform
Price Target: $84
Current: $31.68
Upside: +165.15%
Initiates: Outperform
Price Target: $31
Current: $12.75
Upside: +143.14%
Maintains: Sector Perform
Price Target: $4$3
Current: $1.79
Upside: +67.60%
Reiterates: Sector Perform
Price Target: $4
Current: $2.25
Upside: +77.78%
Maintains: Outperform
Price Target: $139$143
Current: $127.88
Upside: +11.82%
Reiterates: Outperform
Price Target: $40
Current: $35.92
Upside: +11.36%
Reiterates: Outperform
Price Target: $22
Current: $12.40
Upside: +77.42%
Maintains: Sector Perform
Price Target: $25$15
Current: $10.94
Upside: +37.11%
Maintains: Sector Perform
Price Target: $12$9
Current: $5.59
Upside: +61.00%
Maintains: Sector Perform
Price Target: $21$33
Current: $94.51
Upside: -65.08%
Upgrades: Buy
Price Target: n/a
Current: $33.58
Upside: -